Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rapidly Progressive Interstitial Lung Disease”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)Ended earlyNCT01266135
What this trial is testing

Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Looking for participantsNCT07486869
What this trial is testing

Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study

Who this might be right for
DermatomyositisDermatomyositis Sine MyositisDermatomyositis With Myopathy+4 more
University of Miami 5
Testing effectiveness (Phase 2)Study completedNCT02594839
What this trial is testing

Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease

Who this might be right for
Idiopathic Interstitial PneumoniaInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631208
What this trial is testing

Study of the Efficacy and Safety of a Bispecific Antibody, Teclistamab in Severe Rapidly Progressive Interstitial Lung Disease Associated With Anti-MDA5

Who this might be right for
Severe Rapidly Progressive Interstitial Lung Disease Associated With Anti-MDA5
Assistance Publique - Hôpitaux de Paris 24
Early research (Phase 1)Looking for participantsNCT06919380
What this trial is testing

Nebulized MSC-Exos for Anti-MDA5+ RP-ILD: Safety and Efficacy Trial

Who this might be right for
Anti-MDA5 Positive Dermatomyositis-Associated RP-ILDRapidly Progressive Interstitial Lung Disease
Li Shiyue 10
Testing effectiveness (Phase 2)UnknownNCT05181397
What this trial is testing

The Efficacy and Safety of Tocilizumab for Severe RP-ILD Secondary to Systemic Diseases

Who this might be right for
Rapid Progressive Interstitial Lung Diseases
Peking Union Medical College Hospital 68
Not applicableLooking for participantsNCT07775235
What this trial is testing

Treatment Response in Immune-mediated Myositis Associated Rapidly-progressing Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseMyositis
Singapore General Hospital 80
Testing effectiveness (Phase 2)UnknownNCT01450644
What this trial is testing

Evaluation of the Hospital2Home Palliative Care Service for Patients With Advanced Progressive Lung Disease

Who this might be right for
Lung Disease
Royal Marsden NHS Foundation Trust 52
Large-scale testing (Phase 3)Ended earlyNCT05679401
What this trial is testing

A Study With Imlifidase in Anti-GBM Disease

Who this might be right for
Anti-Glomerular Basement Membrane DiseaseAnti-Glomerular Basement Membrane Antibody DiseaseGoodpasture Syndrome+1 more
Hansa Biopharma AB 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07737249
What this trial is testing

Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung Disease

Who this might be right for
Interstitial Lung Diseases
Peking Union Medical College Hospital 60
Not applicableUnknownNCT04613219
What this trial is testing

Correlation Between the Change of Peripheral Lymphocyte Subsets and Clinically Amyopathic Dermatomyositis Combined With Rapidly Progressive Interstitial Lung Disease

Who this might be right for
Clinically Amyopathic Dermatomyisitis(CAMD)
Jing Liang 80